Novel THQ-Triazole hybrids: multitarget ligands as AChE and BChE inhibitors and antioxidant agents

- 342428
Abstract
Favorite this paper
How to cite this paper?
Abstract

A novel series of nitrogen-containing heterocycles combining tetrahydroquinoline (THQ) and triazole scaffolds was successfully designed, synthesized and characterized as potential inhibitors of enzymes related to Alzheimer's disease (acetylcholinesterase/butyrylcholinesterase). The synthetic protocol involved a ZnCl2-catalyzed Povarov reaction for the THQ scaffold, followed by amine propargylation and copper-catalyzed azide-alkyne cycloaddition for the final structure. Given the multifactorial nature of the disease, the compounds were evaluated as cholinesterase inhibitors using Ellman’s Method and as antioxidants (DPPH/ABTS assay). Preliminary screening revealed a remarkable selective antioxidant capacity against ABTS radicals (EC50<10μg/mL), while five of the compounds exhibited a promising dual anticholinesterase profile, highlighting T4 (IC50 AChE=3.77± 0.31 μM, BChE=18.38 ± 0.45 μM) and T13 (IC50 AChE=4.85 ± 0.30 μM, BChE=14.82 ± 0.88 μM).These results were complemented by molecular docking studies to elucidate the binding modes within the enzymatic active sites, concluding that the THQ-Triazole framework represents a promising structure for anti-Alzheimer multitarget drug discovery.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 University of Talca
  • 2 Universidad Andrés Bello
  • 3 University of Concepción
  • 4 Pontificia Universidad Católica de Chile
Track
  • BMOS-2026
Keywords
Nitrogen heterocycles
Cholinesterase inhibitors
Medicinal chemistry
Povarov reaction
Click chemistry